Key regions: Australia, Japan, United States, Germany, Europe
The Anti-Coagulants market in Americas is a growing industry that has seen a significant increase in demand in recent years.
Customer preferences: One of the main reasons for the growth of the Anti-Coagulants market in Americas is due to the increasing prevalence of cardiovascular diseases in the region. As a result, there has been a growing demand for anti-coagulant drugs to manage and prevent these conditions. Additionally, the aging population in the Americas has also contributed to the increase in demand for anti-coagulant drugs.
Trends in the market: The United States is the largest market for anti-coagulant drugs in the Americas, accounting for a significant share of the market. One of the major trends in the US market is the increasing use of direct oral anticoagulants (DOACs) as a first-line treatment for patients with atrial fibrillation. DOACs are preferred over traditional anti-coagulant drugs due to their ease of use and lower risk of bleeding complications.In Canada, the anti-coagulant market is also growing, driven by an aging population and an increasing prevalence of cardiovascular diseases. However, the market is highly competitive, with several major players vying for market share.In Latin America, the anti-coagulant market is still developing, but there is significant potential for growth due to the increasing incidence of cardiovascular diseases in the region. However, the market is highly fragmented, with many local players competing against multinational pharmaceutical companies.
Local special circumstances: In Brazil, the government has implemented price controls on pharmaceutical products, which has led to lower prices for anti-coagulant drugs. This has made these drugs more accessible to the general population, but has also put pressure on pharmaceutical companies to reduce their profit margins.In Mexico, the government has implemented a universal healthcare system, which has led to increased access to healthcare for the general population. This has also led to an increase in demand for anti-coagulant drugs, as more people are being diagnosed with cardiovascular diseases.
Underlying macroeconomic factors: The Anti-Coagulants market in Americas is also influenced by macroeconomic factors such as GDP growth, healthcare spending, and healthcare infrastructure. As the economies of the Americas continue to grow, there is likely to be an increase in demand for healthcare services, including anti-coagulant drugs. Additionally, as healthcare infrastructure improves in the region, there is likely to be an increase in the diagnosis and treatment of cardiovascular diseases, further driving demand for anti-coagulant drugs.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
